# mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer

> **NCT06149689** · PHASE2 · RECRUITING · sponsor: **Fudan University** · enrollment: 30 (estimated)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **COMBINATION_PRODUCT:** mFOLFIRINOX plus radiotherapy

## Key facts

- **NCT ID:** NCT06149689
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-10
- **Primary completion:** 2025-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06149689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06149689, "mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06149689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*